Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition

Gossamer Bio (GOSS.O) said on Monday it will collaborate with Italian drugmaker Chiesi Group to develop and commercialize its therapy seralutinib in multiple indications related to high blood pressure due to constriction of lung arteries.